Jaana Rysä
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiac Valve Diseases and Treatments
- Pharmacology top 1%
- Apelin-related biomedical research
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Signaling Pathways in Disease 9
- Congenital heart defects research 5
-
- Cardiac Fibrosis and Remodeling 20
- Cardiac Valve Diseases and Treatments 8
- Co-authors
- Heikki Ruskoaho (57 shared papers)Mika Ilves (15 shared papers)Hanna Leskinen (18 shared papers)Jukka Hakkola (15 shared papers)Heikki Tokola (11 shared papers)Janne Hukkanen (11 shared papers)Sampsa Pikkarainen (7 shared papers)István Szokodi (5 shared papers)
In The Last Decade
Jaana Rysä
108 papers receiving 2.8k citations
Jaana Rysä's Hit Papers
Peers
Comparison fields: 5 of 132
- Cardiology and Cardiovascular Medicine 729
- Pharmacology 507
- Pharmacology 149
- Endocrinology, Diabetes and Metabolism 261
- Cancer Research 234
Countries citing papers authored by Jaana Rysä
This map shows the geographic impact of Jaana Rysä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaana Rysä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaana Rysä more than expected).
Fields of papers citing papers by Jaana Rysä
This network shows the impact of papers produced by Jaana Rysä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaana Rysä. The network helps show where Jaana Rysä may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaana Rysä, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility Hit paper breakdown → | 2002 | 520 |
| 2 | 2018 | 151 | |
| 3 | 2005 | 102 | |
| 4 | 2016 | 84 | |
| 5 | 2010 | 82 | |
| 6 | 2013 | 70 | |
| 7 | 2014 | 70 | |
| 8 | 2006 | 67 | |
| 9 | 2007 | 61 | |
| 10 | 2010 | 59 | |
| 11 | 2015 | 56 | |
| 12 | 2008 | 56 | |
| 13 | 2006 | 55 | |
| 14 | 2010 | 53 | |
| 15 | 2008 | 53 | |
| 16 | 2023 | 49 | |
| 17 | 2018 | 49 | |
| 18 | 2011 | 44 | |
| 19 | 2018 | 44 | |
| 20 | 2007 | 42 |
About Jaana Rysä
Jaana Rysä is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Oncology and Endocrinology, Diabetes and Metabolism, having authored 115 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (20 papers), Hormonal Regulation and Hypertension (11 papers), Signaling Pathways in Disease (9 papers), Cardiac Valve Diseases and Treatments (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Congenital heart defects research (5 papers) and Cholesterol and Lipid Metabolism (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (729 citations), Pharmacology (507 citations), Pharmacology (149 citations), Endocrinology, Diabetes and Metabolism (261 citations) and Cancer Research (234 citations). Jaana Rysä has collaborated with scholars based in Finland, Sweden and Hungary. Frequent co-authors include Heikki Ruskoaho, Mika Ilves, Hanna Leskinen, Jukka Hakkola, Heikki Tokola, Janne Hukkanen, Sampsa Pikkarainen, István Szokodi, Pasi Tavi and Jarkko Piuhola. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Scientific Reports, PLoS ONE, Blood Pressure and Archives of Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.